Ab Index-Nr. 603-118-00-6

Index-Nr.Internationale chemische BezeichnungEG-Nr.CAS-Nr.EinstufungKennzeichnungbis 30.11.2018: Spezifische Konzentrations-
grenzen,
M-Faktoren
ab 01.12.2018: Spezifische Konzentrations-
grenzen
M-Faktoren und ATE
Anmer-
kungen
Gefahrenklasse, Gefahren-
kategorie und Gefahren-
kodierung
Kodierung der Gefahrenhin-
weise
Piktogramm, Kodierung der SignalworteKodierung der Gefahrenhin-
weise
Kodierung der ergänzenden Gefahren-
merkmale
603-118-00-66-dimethylaminohexan-1-ol404-680-31862-07-3Acute Tox. 4 *
Skin Corr. 1B
Aquatic Chronic 3
H302
H314
H412
GHS05
GHS07
Dgr
H302
H314
H412
   
603-119-00-11,1'-(1,3-phenylenedioxy)bis(3-(2-(prop-2-
enyl)phenoxy)propan-2-ol)
405-840-5Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
   
603-120-00-72-methyl-5-phenylpentanol405-890-825634-93-9Eye Irrit. 2
Skin Irrit. 2
H319
H315
GHS07
Wng
H319
H315
   
603-121-00-24-[4-(1,3-dihydroxyprop-2-yl)phenyla-
mino]-1,8-dihydroxy-5-nitroanthraquinone
406-057-1114565-66-1Carc. 2
Skin Sens. 1
Aquatic Chronic 4
H351
H317
H413
GHS08
GHS07
Wng
H351
H317
H413
   
603-122-00-8sodium 2-ethylhexanolate406-150-738411-13-1Flam. Sol. 1
Skin Corr. 1B
Aquatic Chronic 3
H228
H314
H412
GHS02
GHS05
Dgr
H228
H314
H412
  T
603-123-00-34-methyl-8-methylenetri­cyclo[3.3.1.13,7]
decan-2-ol
406-330-5122760-84-3Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
H315
H317
H411
GHS07
GHS09
Wng
H315
H317
H411
   
603-124-00-91,4-bis[2-(vinyloxy)etho­xy]ben­zene406-900-384563-49-5Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410   
603-125-00-42-(2,4-dichlorophenyl)-1-
(1H–1,2,4-triazol-
1-yl)pent-4-en-2-ol
407-850-589544-40-1Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2
H302
H318
H411
GHS05
GHS07
GHS09
Dgr
H302
H318
H411
   
603-126-00-X2-((4-methyl-2-nitro­phenyl)amino)ethanol408-090-7100418-33-5Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 3
H302
H317
H412
GHS07
Wng
H302
H317
H412
   
603-127-00-5butan-2-ol; [1]
(S)-butan-2-ol; [2]
(R)-butan-2-ol; [3]
(±)-butan-2-ol [4]
201-158-5 [1]
224-168-1 [2]
238-967-8 [3]
240-029-8 [4]
78-92-2 [1]
4221-99-2 [2]
14898-79-4 [3]
15892-23-6 [4]
Flam. Liq. 3
Eye Irrit. 2
STOT SE 3
STOT SE 3
H226
H319
H335
H336
GHS02
GHS07
Wng
H226
H319
H335
H336
  C
603-128-00-02-(phenylmethoxy)naphthalene405-490-3613-62-7Aquatic Chronic 4H413H413   
603-129-00-61-tert-butoxypropan-2-ol406-180-057018-52-7Flam. Liq. 3
Eye Dam. 1
H226
H318
GHS02
GHS05
Dgr
H226
H318
   
603-130-00-1reaction mass of isomers of: α-((dimethyl)biphenyl)-
ω-hydroxypoly(oxy­ethylene)
406-325-8Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412
   
603-131-00-7reaction mass of: 1-deoxy-1-[methyl-(1-
oxododecyl)amino]-D-glucitol;
1-deoxy-1-[methyl-(1-oxotetra­decyl)amino]-D-glucitol (3:1)
407-290-1Eye Dam. 1H318GHS05
Dgr
H318   
603-132-00-22-hydroxymethyl-9-methyl-6-
(1-methylethyl)-1,4-dioxaspi­ro[4.5]decane
408-200-363187-91-7Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 3
H315
H318
H412
GHS05
Dgr
H315
H318
H412
   
603-133-00-8reaction mass of: 3-[(4-amino-2-chloro-5-nitrophenyl)amino]-propane-1,2-diol;
3,3'-(2-chloro-5-nitro-1,4-
phenylenediimino)bis(propan-
1,2-diol)
408-240-1Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412
   
603-134-00-3reaction mass of substituted dodecyl and/or tetradecyl, diphenyl ethers. The substance is produced by the Friedel Crafts reaction. The catalyst is removed from the reaction product. Diphenyl ether is substituted by C1-C10 alkyl groups. The alkyl groups are bonded randomly between C1 and C6. Linear C12 and C14, 50/50 used.410-450-3Aquatic Chronic 4H413H413   
603-135-00-9bis[[2,2',2''-nitrilotris-[ethano­lato]]-1-N,O]-bis[2-(2-methoxy­ethoxy)ethoxy]-titanium410-500-4Eye Dam. 1
Aquatic Chronic 2
H318
H411
GHS05
GHS09
Dgr
H318
H411
   
603-136-00-43-((4-(bis(2-hydroxyethyl)ami­no)-2-nitro-phenyl)amino)-1-
propanol
410-910-3104226-19-9Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
   
603-137-00-Xreaction mass of: 1-deoxy-1-[methyl-(1-
oxohexadecyl)amino]-D-glucitol;
1-deoxy-1-[methyl-(1-oxoocta­decyl)amino]-D-glucitol
411-130-6Eye Dam. 1H318GHS05
Dgr
H318   
603-138-00-53-(2,2-dimethyl-3-hydroxy­propyl)toluene;
(alt.): 2,2-dimethyl-3-(3-methyl­phenyl)propanol
403-140-4103694-68-4Aquatic Chronic 3H412H412   
603-139-00-0bis(2-methoxyethyl) ether203-924-4111-96-6Flam. Liq. 3
Repr. 1B
H226
H360FD
GHS02
GHS08
Dgr
H226
H360FD
EUH019  
603-140-00-62,2' -oxybisethanol;
diethylene glycol
203-872-2111-46-6Acute Tox. 4 *H302GHS07
Wng
H302   
603-141-00-1reaction mass of: dodecyloxy-1-methyl-1-
[oxy-poly-(2-hydroxymethyl­ethanoxy)]pentadecane;
dodecyloxy-1-methyl-1-[oxy-
poly-(2-hydroxymethyl­ethanoxy)]heptadecane
413-780-6Aquatic Chronic 3H412H412   
603-142-00-72-(2-(2-hydroxyethoxy)ethyl)-2-
aza-bicyclo[2.2.1]heptane
407-360-1116230-20-7Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Skin Irrit. 2
Eye Dam. 1
H312
H302
H373 **
H315
H318
GHS06
GHS08
GHS05
Dgr
H312
H302
H373 **
H315
H318
   
603-143-00-2R–2,3-epoxy-1-propanol404-660-457044-25-4Self-react. C ****
Carc. 1B
Muta. 2
Repr. 1B
Acute Tox. 3 *
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
H242
H350
H341
H360F ***
H331
H312
H302
H314
GHS02
GHS06
GHS08
GHS05
Dgr
H242
H350
H341
H360F ***
H331
H312
H302
H314
   
603-144-00-8reaction mass of: 2,6,9-trimethyl-2,5,9-cyclo­dodecatrien-1-ol;
6,9-dimethyl-2-methylen-5,9-
cyclododecadien-1-ol
413-530-6111850-00-1Aquatic Chronic 2H411GHS09H411   
603-145-00-32-isopropyl-2-(1-methylbutyl)-1,3-dimethoxypropane406-970-5129228-11-1Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Wng
H315
H411
   
603-146-00-92-[(2-[2-(dimethylamino)etho­xy]ethyl)
methylamino]ethanol
406-080-783016-70-0Acute Tox. 4 *
Skin Corr. 1B
Aquatic Chronic 3
H302
H314
H412
GHS05
GHS07
Dgr
H302
H314
H412
   
603-147-00-4(-)-trans-4-(4'-fluorophenyl)-3-
hydroxymethyl-N-methyl­piperidine
406-030-4105812-81-5Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2
H302
H318
H411
GHS05
GHS07
GHS09
Dgr
H302
H318
H411
   
603-148-00-X1,4-bis[(vinyloxy)methyl]cyclo­hexane413-370-717351-75-6Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07 GHS09
Wng
H317
H411
   
603-149-00-5reaction mass of diastereoisomers of 1-(1-
hydroxyethyl)-4-(1-methylethyl)cyclohexane
407-640-363767-86-2Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 2
H319
H315
H411
GHS07 GHS09
Wng
H319
H315
H411
   
603-150-00-0(±) trans–3,3-dimethyl-5-(2,2,3-trimethyl-cyclopent-3-en-
1-yl)-pent-4-en-2-ol
411-580-3107898-54-4Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H315
H400
H410
GHS07
GHS09
Wng
H315
H410
   
603-151-00-6(±)-2-(2,4-dichloro­phenyl)-3-(1H–1,2,4-
triazol-1-yl)propan-1-ol
413-570-4Aquatic Chronic 3H412H412   
603-152-00-12-(4-tert-butylphenyl)ethanol410-020-55406-86-0Repr. 2
STOT RE 2 *
Eye Dam. 1
Aquatic Chronic 2
H361f ***
H373 **
H318
H411
GHS08
GHS05
GHS09
Dgr
H361f ***
H373 **
H318
H411
   
603-153-00-73-((2-nitro-4-(trifluorome­thyl)phenyl)amino)propane-1,2-diol410-010-0104333-00-8Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412
   
603-154-00-21-[(2-tert-butyl)cyclohexyloxy]-
2-butanol
412-300-2139504-68-0Aquatic Chronic 2H411GHS09H411   
603-156-00-32-(2,4-dichlorophenyl)-2-(2-
propenyl)oxirane
411-210-089544-48-9Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H317
H400
H410
GHS07
GHS09
Wng
H315
H317
H410
   
603-157-00-96,9-bis(hexadecyloxymethyl)-
4,7-dioxano-nane-1,2,9-triol
411-450-6143747-72-2Aquatic Chronic 4H413H413   
603-158-00-4reaction mass of 4 diastereoiso­mers of 2,7-dimethyl-10-(1-methylethyl)-1-oxaspiro[4.5]deca-3,6-diene412-460-3Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07 GHS09
Wng
H315
H411
   
603-159-00-X2-cyclododecylpropan-1-ol411-410-8118562-73-5Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410   
603-160-00-51,2-diethoxypropane412-180-110221-57-5Flam. Liq. 2H225GHS02
Dgr
H225EUH019  
603-161-00-01,3-diethoxypropane413-140-63459-83-4Flam. Liq. 3H226GHS02
Wng
H226   
603-162-00-6α[2-[[[(2-hydroxyethyl)methylamino]acetyl]
amino]propyl]- ω nonylphenoxy)poly[oxo
(methyl-1,2-ethanediyl)]
413-420-8144736-29-8Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 2
H314
H317
H411
GHS05
GHS07
GHS09
Dgr
H314
H317
H411
   
603-163-00-12-phenyl-1,3-propanediol411-810-21570-95-2Eye Dam. 1H318GHS05
Dgr
H318   
603-164-00-72-butyl-4-chloro-4,5-dihydro-5-
hydroxyme-thyl-1-[2'-(2-
triphenylmethyl-1,2,3,4-2H-
tetrazol-5-yl)-1,1'-biphenyl-4-
methyl]-1H-imidazole
412-420-5133909-99-6Aquatic Chronic 4H413H413   
603-165-00-2reaction mass of: 4-allyl-2,6-bis(2,3-epoxy-
propyl)phenol;
4-allyl-6-[3-[6-[3-[6-[3-(4-allyl-
2,6-bis(2,3-epoxypropyl)phe­noxy)-2-hydroxypropyl]-4-
allyl-2-(2,3-epoxypropyl)phe­noxy]-2-hydroxypropyl]-4-allyl-2-(2,3-epoxypropyl)phe-
noxy]-2-hydroxypropyl]-2-(2,3-
epoxypro-pyl)phenol;
4-allyl-6-[3-(4-allyl-2,6-bis(2,3-
epoxypro-pyl)phenoxy)-2-
hydroxypropyl]-2-(2,3-epo-
xypropyl)phenol;
4-allyl-6-[3-[6-[3-(4-allyl-2,6-
bis(2,3-epoxy-propyl)phenoxy)-2-hydroxypropyl]-4-allyl-2-(2,3-
epoxypropyl)phenoxy]-2-
hydroxy-propyl]-2-(2,3-
epoxypropyl)phenol
417-470-1Muta. 2
Skin Sens. 1
H341
H317
GHS08
GHS07
Wng
H341
H317
   
603-166-00-8R-1-chloro-2,3-epoxypropane424-280-251594-55-9Flam. Liq. 3
Carc. 1B
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B
Skin Sens. 1
H226
H350
H331
H311
H301
H314
H317
GHS02
GHS06
GHS08
GHS05
Dgr
H226
H350
H331
H311
H301
H314
H317
   
603-167-00-33,3',5,5'-tetra-tert-butylbiphenyl-2,2'-diol407-920-56390-69-8Aquatic Chronic 4H413GHS05
Dgr
H413   
603-168-00-93-(2-ethylhexyloxy)propane-1,2-diol408-080-270445-33-9Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412
   
603-169-00-4(±)-trans-4-(4-fluoro­phenyl)-3-hydroxy­methyl-N-methylpiperidine415-550-0109887-53-8Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2
H302
H318
H411
GHS05
GHS07
GHS09
Dgr
H302
H318
H411
   
603-170-00-Xreaction mass of: 2-methyl-1-(6-methylbicy­clo[2.2.1]hept-5-en-2-yl)pent-1-en-3-ol;
2-methyl-1-(1-methylbicy­clo[2.2.1]hept-5-en-2-yl)-pent-1-
en-3-ol;
2-methyl-1-(5-methylbicy­clo[2.2.1]hept-5-en-2-yl)pent-1-
en-3-ol
415-990-367739-11-1Eye Irrit. 2
Aquatic Chronic 2
H319
H411
GHS07
GHS09
Wng
H319
H411
   
603-171-00-55-thiazolylmethanol414-780-938585-74-9Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412
   
603-172-00-0mono-2-[2-(4-diben-
zo[b,f][1,4]thiazepin-11-yl)pi-
perazinium-1-yl]ethoxy)ethanol
trans-butenedioate
415-180-1773058-82-5Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2
H302
H318
H411
GHS05
GHS07
GHS09
Dgr
H302
H318
H411
   
603-173-00-64,4-dimethyl-3,5,8-trioxabicy-
clo[5.1.0]octane
421-750-957280-22-5Eye Irrit. 2
Skin Sens. 1
H319
H317
GHS07
Wng
H319
H317
   
603-174-00-14-cyclohexyl-2-methyl-2-butanol420-630-383926-73-2Eye Dam. 1
Aquatic Chronic 2
H318
H411
GHS05
GHS09
Dgr
H318
H411
   
603-175-00-72-(2-hexyloxyethoxy)ethanol;
DEGHE;
diethylene glycol monohexyl ether;
3,6-dioxa-1-dodecanol;
hexyl carbitol;
3,6-dioxadodecan-1-ol
203-988-3112-59-4Acute Tox. 4 *
Eye Dam. 1
H312
H318
GHS05
GHS07
Dgr
H312
H318
   
603-176-00-21,2-bis(2-methoxyethoxy)etha­ne;
TEGDME;
triethylene glycol dimethyl ether;
triglyme
203-977-3112-49-2Repr. 1BH360DfGHS08
Dgr
H360DfEUH019  
603-177-00-81-ethoxypropan-2-ol;
2PG1EE;
1-ethoxy-2-propanol;
propylene glycol monoethyl ether; [1]
2-ethoxy-1-methylethyl acetate;
2PG1EEA [2]
216-374-5 [1]
259-370-9 [2]
1569-02-4 [1]
54839-24-6 [2]
Flam. Liq. 3
STOT SE 3
H226
H336
GHS02
GHS07
Wng
H226
H336
   
603-178-00-32-hexyloxyethanol;
ethylene glycol monohexyl ether;
n-hexylglycol
203-951-1112-25-4Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
H312
H302
H314
GHS05
GHS07
Dgr
H312
H302
H314
   
603-179-00-9ergocalciferol (ISO);
Vitamin D2
200-014-950-14-6Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 1
H330
H311
H301
H372 **
GHS06
GHS08
Dgr
H330
H311
H301
H372 **
   
603-180-00-4colecalciferol;
Vitamin D3
200-673-267-97-0Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 1
H330
H311
H301
H372 **
GHS06
GHS08
Dgr
H330
H311
H301
H372 **
   
603-181-00-Xtert-butyl methyl ether;
MTBE;
2-methoxy-2-methylpropane
216-653-11634-04-4Flam. Liq. 2
Skin Irrit. 2
H225
H315
GHS02
GHS07
Dgr
H225
H315
   
603-182-00-5reaction product of: saturated,
monounsaturated and multiple
unsaturated long-chained partly
estrified alcohols of vegetable origin
(Brassica napus L., Brassica rapa L.,
Helianthus annuus L., Glycine hispida,
Gossypium hirsutum L., Cocos nucifera L.,
Elaeis guineensis) with
O,O-diisobutyldithiophosphate and
2-ethylhexylamine and hydrogen
peroxide
428-630-5Skin Sens. 1H317GHS07
Wng
H317   
603-183-00-02-[2-(2-butoxyethoxy)ethoxy]ethanol;
TEGBE;
triethylene glycol monobutyl ether;
butoxytriethylene glycol
205-592-6143-22-6Eye Dam. 1H318GHS05
Dgr
H318 Eye Dam. 1;
H318: C ≥ 30 %
Eye Irrit. 2; H319:
20 % ≤ C < 30 %
 
603-184-00-62-(hydroxymethyl)-2-[[2-
hydroxy-3-(isooctadecy­loxy)propoxy]methyl]-1,3-
propanediol
416-380-1146925-83-9Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410   
603-185-00-12,4-dichloro-3-ethyl-6-nitrophenol420-740-199817-36-4Acute Tox. 3 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H301
H318
H317
H400
H410
GHS06
GHS05
GHS09
Dgr
H301
H318
H317
H410
   
603-186-00-7trans-(5RS,6SR)-6-amino-2,2-dimethyl-1,3-
dioxepan-5-ol
419-050-379944-37-9Skin Sens. 1H317GHS07
Wng
H317   
603-187-00-22-((4,6-bis(4-(2-(1-methylpyridinium-4-yl)
vinyl)phenylamino)-1,3,5-triazin-2-yl)(2-
hydroxyethyl)amino)ethanol dichloride
419-360-9163661-77-6Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410   
603-188-00-8reaction mass of: 6,7-epoxy-
1,2,3,4,5,6,7,8-octahydro-
1,1,2,4,4,7-hexamethyl-
naphthalene;
7,8-epoxy-1,2,3,4,6,7,8,8a-
octahydro-1,1,2,4,4,7-
hexamethylnaphthalene
426-970-9Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410   
603-189-00-3reaction mass of complexes of: titanium,
2,2'-oxydiethanol, ammonium lactate, nitrilotris(2-propanol) and ethylene glycol
405-250-8Aquatic Chronic 2H411GHS09H411   
603-190-00-98,8-dimethyl-7-isopropyl-6,10-
dioxaspiro[4.5]decane
424-030-262406-73-9Skin Irrit. 2
Aquatic Chronic 3
H315
H412
GHS07
Wng
H315
H412
   
603-191-00-42-(4,6-bis(2,4-dimethylphenyl)-
1,3,5-triazin-2-yl)-5-(3-((2-
ethylhexyl)oxy)-2-hydro-
xypropoxy)phenol
419-740-4137658-79-8Aquatic Chronic 4H413H413   
603-192-00-X(E,E)-3,7,11-trimethyldodeca-
1,4,6,10-tetraen-3-ol
423-240-1125474-34-2Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H318
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H315
H318
H317
H410
   
603-193-00-5disodium 9,10-anthracenedioxide426-030-846492-07-3Skin Corr. 1AH314GHS05
Dgr
H314   
603-194-00-02-(2-aminoethylamino)ethanol;
(AEEA)
203-867-5111-41-1Repr. 1B
Skin Corr. 1B
Skin Sens. 1
H360Df
H314
H317
GHS05
GHS08
GHS07
Dgr
H360Df
H314
H317
 STOT SE 3; H335:
C ≥ 5 %
 
603-195-00-62-[4-(4-methoxyphenyl)-6-
phenyl-1,3,5-triazin-2-yl]-phenol
430-810-3154825-62-4Aquatic Chronic 3H412H412   
603-196-00-12-(7-ethyl-1H-indol-3-yl)ethanol431-020-141340-36-7Acute Tox. 4 *
STOT RE 2 *
Aquatic Chronic 2
H302
H373 **
H411
GHS08
GHS07
GHS09
Wng
H302
H373 **
H411
   
603-197-00-7Tebuconazol (ISO);
1-(4-Chlorphenyl)-4,4-dimethyl-
3-(1,2,4-triazol-1-ylmethyl)pen-
tan-3-ol
403-640-2107534-96-3Repr. 2
Acute Tox. 4
Aquatic Acute 1
Aquatic Chronic 1
H361d ***
H302
H400
H410
GHS08
GHS07
GHS09
Wng
H361d ***
H302
H410
 M = 1
M = 10
 
603-199-00-8etoxazol (ISO);
(RS)-5-tert-butyl-2-[2-(2,6-di-
fluorophenyl)-4,5-dihydro-1,3-
oxazol-4-yl]phenetole
153233-91-1Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410 M = 100 
603-200-00-11-pentanol; [1]
3-pentanol [2]
200-752-1 [1]
209-526-7 [2]
71-41-0 [1]
584-02-1 [2]
Flam. Liq. 3
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
H226
H332
H335
H315
GHS02
GHS07
Wng
H226
H332
H335
H315
   
603-201-00-7(E)-(7R,11R)-3,7,11,15-
tetramethylhexadec-2-ene-1-ol
416-120-5Skin Irrit. 2
Aquatic Chronic 4
H315
H413
GHS07
Wng
H315
H413
   
603-202-00-24,4,5,5,5-pentafluoropentan-1-ol421-360-9148043-73-6Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412
   
603-203-00-8(1R,3S,7R,8R,10R,13R)-5,5,7,9,9,13-hexamethyl-4,6-dioxatetracyclo[6.5.1.01,10.03,7]tetradecane427-580-1Skin Irrit. 2H315GHS07
Wng
H315   
603-204-00-3reaction mass of: 2,2´-(heptane-1,7-diyl)bis-1,3-dioxolane;
2,2´-(heptane-1,6-diyl)bis-1,3-
dioxolane
428-110-8Aquatic Chronic 3H412H412   
603-205-00-9(1S-cis)-4-(2-amino-6-chloro-9H-
purin-9-yl)-2-cyclopentene-1-
methanol hydrochloride
426-200-1172015-79-1STOT RE 1
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H372 **
H302
H318
H317
H412
GHS05
GHS08
GHS07
Dgr
H372 **
H302
H318
H317
H412
   
603-206-00-42,2-dichloro-1,3-benzodioxol426-850-62032-75-9Flam. Liq. 3
Skin Corr. 1A
Acute Tox. 4 *
Skin Sens. 1
H226
H314
H302
H317
GHS02
GHS05
GHS07
Dgr
H226
H314
H302
H317
EUH014  
603-207-00-X2-isobutyl-2-isopropyl-1,3-
dimethoxypropane
430-800-9129228-21-3Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Wng
H315
H411
   
603-208-00-51,2-diethoxyethane211-076-1629-14-1Flam. Liq. 2
Repr. 1A
Eye Irrit. 2
H225
H360Df
H319
GHS02
GHS08
GHS07
Dgr
H225
H360Df
H319
EUH019  
603-209-00-0spinosad (ISO) (reaction mass of spinosyn A and spinosyn D in ratios between 95:5 to 50:50); reaction mass of 50-95 % of (2R,3aS,5aR,5bS,9S,13S,14-
R,16aS,16bR)-2-(6-deoxy-
2,3,4-tri-O-methyl-α-l-
mannopyranosyloxy)-13-(4-
dimethylamino-2,3,4,6-
tetradeoxy-β-d-erythropy­ranosyloxy)-9-ethyl-
2,3,3a,5a,5b,6,7,9,10,11,12,13,
14,15,16a,16b-hexadecahydro-
14-methyl-1H-8-oxacyclodo-
deca[b]as-indacene-7,15-dione and 50-5 % (2S,3aR,5aS,5bS,9S,13S,14R,
16aS,16bS)-2-(6-deoxy-2,3,4-tri-O-methyl-α-l-mannopy-
ranosyloxy)-13-(4-dimethyla-
mino-2,3,4,6-tetradeoxy-β-d-erythropyranosyloxy)-9-ethyl-2,3,3a,5a,5b,6,7,9,10,11,12,13,
14,15,16a,16b-hexadecahydro-
4,14-dimethyl-1H-8-oxacyclo-
dodeca[b]as-indacene-7,15-
dione; [1]
spinosyn A; [2]
spinosyn D [3]
- [1]
- [2]
- [3]
- [1]
131929-60-7 [2]
131929-63-0 [3]
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410 M = 10 
603-210-00-62,4-diethyl-1,5-pentanediol429-310-857987-55-0Eye Dam. 1H318GHS05
Dgr
H318   
603-211-00-12,3-epoxypropyltrimethylammo­nium chloride ... %;
glycidyl trimethylammonium chloride ... %
221-221-03033-77-0Carc. 1B
Muta. 2
Repr. 2
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H350
H341
H361f ***
H312
H302
H373 **
H318
H317
H412
GHS05
GHS08
GHS07
Dgr
H350
H341
H361f ***
H312
H302
H373 **
H318
H317
H412
  B
603-212-00-71,3,4,6,7,8-hexahydro-
4,6,6,7,8,8-hexamethylin-
deno[5,6-c]pyran;
galaxolide;
(HHCB)
214-946-91222-05-5Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410   
603-213-00-22-methoxy-2-methylbutane;
tert-amyl methyl ether
213-611-4994-05-8Flam. Liq. 2
Acute Tox. 4 *
STOT SE 3
H225
H302
H336
GHS02
GHS07
Dgr
H225
H302
H336
   
603-214-00-81,1-diisopropoxycyclohexane413-740-81132-95-2Skin Corr. 1BH314GHS05
Dgr
H314   
603-215-00-31-hydroxy-4-fluoro-1,4-
diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate)
418-330-2162241-33-0Expl. 1.1****
Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H201
H302
H373 **
H318
H317
H400
H410
GHS01
GHS05
GHS08
GHS07
GHS09
Dgr
H201
H302
H373 **
H318
H317
H410
   
603-216-00-9cis-1-amino-2,3-dihydro-1H-
inden-2-ol
422-660-27480-35-5Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H318
H317
H412
GHS05
GHS07
Dgr
H318
H317
H412
   
603-217-00-42,4,6-tri-tert-butylphenyl 2-butyl-2-ethyl-1,3-propane­diolphosphite423-560-1161717-32-4Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
   
603-220-00-01-{benzyl[2-(2-methoxyphe­noxy)ethyl]amino}-3-(9H-
carbazol-4-yloxy)propan-2-ol
432-890-572955-94-3Aquatic Chronic 4H413H413   
603-221-00-61-(2-amino-5-chlorophenyl)-
2,2,2-trifluoro-1,1-ethanediol, hydrochloride;
[containing < 0,1 % 4-chloroaniline
(EC No 203-401-0)]
433-580-2214353-17-0Acute Tox. 4 *
Skin Corr. 1B
Aquatic Chronic 2
H302
H314
H411
GHS05
GHS07
GHS09
Dgr
H302
H314
H411
   
603-221-01-31-(2-amino-5-chlorophenyl)-
2,2,2-trifluoro-1,1-ethanediol, hydrochloride;
[containing ≥ 0,1 % 4-chloroaniline
(EC No 203-401-0)]
433-580-2214353-17-0Carc. 1B
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Chronic 2
H350
H302
H314
H411
GHS05
GHS08
GHS07
GHS09
Dgr
H350
H302
H314
H411
   
603-222-00-1(2R,3S,4R,5R,7R,9R,10R,11S,
12S,13R)-10-[(4-dimethylami-
no-3-hydroxy-6-methyltetrahyd-
ropyran-2-yl)oxy]-2-ethyl-
3,4,12-trihydroxy-9-methoxy-
3,5,7,9,11,13-hexamethyl-6,14-
dioxo-1-oxacyclotetradecane
433-820-6118058-74-5Eye Irrit. 2H319GHS07
Wng
H319   
603-223-00-72-cyclopentylidene cyclopentanol;
1,1´-bi(cyclopentyliden)-2-ol
434-270-16261-30-9Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 3
H315
H318
H412
GHS05
Dgr
H315
H318
H412
   
603-224-00-23-ethoxy-1,1,1,2,3,4,4,5,5,6,6,6-
dodecafluoro-2-(trifluoromethyl)-
hexane
435-790-1297730-93-9Aquatic Chronic 4H413H413   
603-225-00-8erythromycin A9-oxime (E);
(3R,4S,5S,6R,7R,9R,11R,12R,
13S,14R)-4-((2,6-didesoxy-3-
C-methyl-3-O-methyl-α-L-
ribo-hexopiranosyl)oxy)-14-
ethyl-7,12,13-trihydroxy-
3,5,7,9,11,13-hexamethyl-6-
((3,4,6-tridesoxy-3-dimethyla-
mino-β-d-xylohexapirano-
syl)oxy)oxacyclotetradecan-2-
ona-10-oxime (E)
437-070-013127-18-9Aquatic Chronic 2H411GHS09H411   
603-226-00-34,4´(4-(4-methoxyphenyl)-1,3,5-
triazin-2,4-diyl)bisbenzene-1,3-
diol
444-500-01440-00-2Aquatic Chronic 3H412H412   
603-227-00-9α-hydro-ω-[[[(1,1-
dimethylethyl)dioxy]carbo-
nyl]oxy]poly[oxy(methyl-1,2-
ethanediyl)]ether with 2,2-bis(hydroxymethyl)-
1,3-propanediol (4:1);
reaction product of: α-hydro-ω-
((chlorocarbonyl)oxy)-
poly(oxy(methyl-1,2-ethanediyl))
ether with 2,2-bis(hydroxymethyl)-
1,3-propanediol with potassium
1,1-dimethylethylperoxalate
445-060-2203574-04-3****
Aquatic Acute 1
Aquatic Chronic 1
****
H400
H410
****
GHS09
Wng
****
H410
   
603-228-00-4(+/–)-(R*,R*)-6-fluoro-3,4-
dihydro-2-oxiranyl-2H-1-
benzopyran;
6-fluoro-2-(2-oxiranyl)chromane
419-620-1Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
   
603-229-00-Xsodium
(Z)-3-chloro-3-(4-chlorophenyl)-1-
hydroxy-2-propene-1-sulfonate
420-800-7Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H318
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H315
H318
H317
H410
   
603-230-00-52,6,6,7,8,8-hexamethylde-
cahydro-2H-indeno[4,5-b]furan
440-030-5Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 4
H315
H318
H413
GHS05
Dgr
H315
H318
H413
   
603-231-00-0(S)-1,1-diphenyl-1,2-propanediol443-220-6Aquatic Chronic 3H412H412   
603-232-00-63,3,8,8,10,10-hexamethyl-9-
[1-(4-oxiranylmethoxy-phenyl)-
ethoxy]-1,5-dioxa-9-aza-
spiro[5.5]undecane
444-420-6Aquatic Chronic 4H413H413   
603-233-00-1reaction mass of: 4-(1,3a,4,6,7,7a-
hexahydro-4,7-methanoinden-5-
ylidene)-3-methylbutan-2-ol;
4-(3,3a,4,6,7,7a-hexahydro-4,7-
methanoinden-5-ylidene)-3-
methylbutan-2-ol;
1-(1,3a,4,6,7,7a-hexahydro-4,7-
methanoinden-5-ylidene)pentan-3-ol;
1-(3,3a,4,6,7,7a-hexahydro-4,7-
methanoinden-5-ylidene)pentan-3-ol;
(E)-4-(3a,4,5,6,7,7a-hexahydro-1H-
4,7-methanoinden-5-yl)-3-
methylbut-3-en-2-ol;
(E)-4-(3a,4,5,6,7,7a-hexahydro-3H-
4,7-methanoinden-5-yl)-3-
methylbut-3-en-2-ol
444-430-0Aquatic Chronic 2H411GHS09H411   
603-234-00-7(1R,4R)-4-methoxy-2,2,7,7-
tetramethyltricyclo(6.2.1.0(1,6))
undec-5-ene
444-480-3Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Wng
H315
H411
   
ab 01.12.2018*):
*) Die harmonisierten Einstufungen dürfen bereits vor dem genannten Datum verwendet werden.
603-235-00-2
Linalool: 3,7-Dimethyl-
1,6-octadien-3-ol; DL-Linalool; [1]
Coriandrol; (S)-3,7-Dimethyl-1,6-
octadien-3-ol; D-Linalool; [2]
Licareol; (R)-3,7-Dimethyl-1,6-
octadien-3-ol; L-Linalool [3]
201-134-4 [1]
204-810-7 [2]
204-811-2 [3]
78-70-6 [1]
126-90-9 [2]
126-91-0 [3]
Skin Sens. 1BH317GHS07
Wng
H317   
604-001-00-2phenol;
carbolic acid;
monohydroxybenzene;
phenylalcohol
203-632-7108-95-2Muta. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Skin Corr. 1B
H341
H331
H311
H301
H373 **
H314
GHS06
GHS08 GHS05
Dgr
H341
H331
H311
H301
H373 **
H314
 *
Skin Corr. 1B;
H314: C ≥ 3 %
Skin Irrit. 2;
H315: 1 % ≤ C <
3%
Eye Irrit. 2; H319:
1% ≤ C < 3%